Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Page 1
Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
Bayer V, Kotalczyk A, Kea B, Teutsch C, Larsen P, Button D, Huisman MV, Lip GYH, Olshansky B. Bayer V, et al. Among authors: teutsch c. J Am Heart Assoc. 2022 Mar 15;11(6):e023907. doi: 10.1161/JAHA.121.023907. Epub 2022 Mar 4. J Am Heart Assoc. 2022. PMID: 35243870 Free PMC article.
Methods and Results Eligible participants were recruited into GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation), a prospective observational cohort study from 2014 to 2016 in 4 international regions: North America, …
Methods and Results Eligible participants were recruited into GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment i …
Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world.
Kozieł M, Teutsch C, Bayer V, Lu S, Gurusamy VK, Halperin JL, Rothman KJ, Diener HC, Ma CS, Huisman MV, Lip GYH; GLORIA‐AF Investigators. Kozieł M, et al. Among authors: teutsch c. J Arrhythm. 2021 Jul 10;37(4):990-1006. doi: 10.1002/joa3.12588. eCollection 2021 Aug. J Arrhythm. 2021. PMID: 34386125 Free PMC article.
OBJECTIVES: To assess changes in anticoagulant prescription patterns in various geographical regions upon first approval of a NOAC and to analyze the evolution of oral anticoagulants (OACs) use over time in relation to CHA(2)DS(2)-VASc and HAS-BLED risk profiles. METHODS: Global …
OBJECTIVES: To assess changes in anticoagulant prescription patterns in various geographical regions upon first approval of a NOAC and to an …
Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program.
Azar RR, Ragy HI, Kozan O, El Khuri M, Bazergani N, Marler S, Teutsch C, Ibrahim M, Lip GYH, Huisman MV. Azar RR, et al. Among authors: teutsch c. Int J Cardiol Heart Vasc. 2021 Apr 10;34:100763. doi: 10.1016/j.ijcha.2021.100763. eCollection 2021 Jun. Int J Cardiol Heart Vasc. 2021. PMID: 33912651 Free PMC article.
METHODS AND RESULTS: This study used prospectively collected data from the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation (GLORIA-AF) to describe anticoagulant use and outcomes in Africa and the Middle East. ...
METHODS AND RESULTS: This study used prospectively collected data from the Global Registry on Long-Term Oral Antithrombotic Treatment …
Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF.
van der Wall SJ, Teutsch C, Dubner SJ, Diener HC, Halperin JL, Ma CS, Rothman KJ, Paquette M, Zint K, França LR, Lu S, Lip GYH, Huisman MV; GLORIA-AF Investigators. van der Wall SJ, et al. Among authors: teutsch c. TH Open. 2021 Feb 6;5(1):e35-e42. doi: 10.1055/s-0040-1722706. eCollection 2021 Jan. TH Open. 2021. PMID: 33564743 Free PMC article.
This study aimed to evaluate anticoagulation prescription patterns in relation to renal function and to describe 2-year clinical outcomes among dabigatran users. Methods Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA …
This study aimed to evaluate anticoagulation prescription patterns in relation to renal function and to describe 2-year clinical outcomes am …
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry.
Ntaios G, Huisman MV, Diener HC, Halperin JL, Teutsch C, Marler S, Gurusamy VK, Thompson M, Lip GYH, Olshansky B; GLORIA-AF Investigators. Ntaios G, et al. Among authors: teutsch c. Hellenic J Cardiol. 2021 Mar-Apr;62(2):152-157. doi: 10.1016/j.hjc.2020.11.009. Epub 2020 Dec 15. Hellenic J Cardiol. 2021. PMID: 33338644 Free article. Clinical Trial.
METHODS AND RESULTS: We analyzed the Phase III dataset of the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF), a large, global, prospective global registry of patients with newly diagnosed AF and 1 stroke risk fac …
METHODS AND RESULTS: We analyzed the Phase III dataset of the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients …
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF.
Dubner SJ, Teutsch C, Huisman MV, Diener HC, Halperin J, Rothman KJ, Ma CS, Chuquiure-Valenzuela E, Bergler-Klein J, Zint K, Riou França L, Lu S, Paquette M, Lip GYH. Dubner SJ, et al. Among authors: teutsch c. ESC Heart Fail. 2020 Oct;7(5):2679-2689. doi: 10.1002/ehf2.12857. Epub 2020 Jul 2. ESC Heart Fail. 2020. PMID: 32613745 Free PMC article.
Stroke and major bleeding rates were roughly comparable between groups confirming the long-term safety and effectiveness of dabigatran in patients with HF....
Stroke and major bleeding rates were roughly comparable between groups confirming the long-term safety and effectiveness of dabigatra …
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry.
Ma C, Riou França L, Lu S, Diener HC, Dubner SJ, Halperin JL, Li Q, Paquette M, Teutsch C, Huisman MV, Lip GYH, Rothman KJ; GLORIA‐AF Investigators. Ma C, et al. Among authors: teutsch c. J Arrhythm. 2020 Mar 10;36(3):408-416. doi: 10.1002/joa3.12321. eCollection 2020 Jun. J Arrhythm. 2020. PMID: 32528565 Free PMC article.
This analysis explored whether availability of non-vitamin K antagonist oral anticoagulants post-dabigatran approval was associated with changing treatment patterns in China. METHODS: Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibril …
This analysis explored whether availability of non-vitamin K antagonist oral anticoagulants post-dabigatran approval was associated with cha …
Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program.
Boriani G, Huisman MV, Teutsch C, Marler S, França LR, Lu S, Lip GYH; GLORIA-AF Investigators. Boriani G, et al. Among authors: teutsch c. Eur J Intern Med. 2020 Oct;80:35-44. doi: 10.1016/j.ejim.2020.04.032. Epub 2020 May 13. Eur J Intern Med. 2020. PMID: 32414640
METHODS: Patients with newly diagnosed non-valvular AF (<3 months) with 1 stroke risk factors enrolled in the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) in Asia, Europe and North America were evaluated. .. …
METHODS: Patients with newly diagnosed non-valvular AF (<3 months) with 1 stroke risk factors enrolled in the Global Registry on Long- …
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.
Mazurek M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Paquette M, Zint K, França LR, Lu S, Bartels DB, Huisman MV, Lip GYH; GLORIA-AF Investigators. Mazurek M, et al. Among authors: teutsch c. Am Heart J. 2019 Dec;218:123-127. doi: 10.1016/j.ahj.2019.08.012. Am Heart J. 2019. PMID: 31806087
GLORIA-AF is a large, ongoing, prospective, global registry program run in 3 phases, assessing long-term safety and effectiveness of dabigatran etexilate (dabigatran) in patients with newly diagnosed atrial fibrillation (AF) in clinical practice. ...
GLORIA-AF is a large, ongoing, prospective, global registry program run in 3 phases, assessing long-term safety and effectiveness of …
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
Mazurek M, Halperin JL, Huisman MV, Diener HC, Dubner SJ, Ma CS, Rothman KJ, Healey JS, Teutsch C, Paquette M, França LR, Lu S, Bartels DB, Lip GYH. Mazurek M, et al. Among authors: teutsch c. Europace. 2020 Jan 1;22(1):47-57. doi: 10.1093/europace/euz278. Europace. 2020. PMID: 31651951
AIMS: To assess antithrombotic therapy choices in relation to patient age in a large, global registry on atrial fibrillation (AF). METHODS AND RESULTS: Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) is an interna …
AIMS: To assess antithrombotic therapy choices in relation to patient age in a large, global registry on atrial fibrillation (AF). METHODS A …
19 results